Company News

Curcumin’s Role in Oral Care

Sabinsa publishes promising results from new research.

Author Image

By: TOM BRANNA

Editor

Sabinsa has published research building on evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct ingredient in oral care applications.   Tetrahydrocurcuminoids (THCs) are among the major active metabolites formed on oral curcuminoids ingestion. The myriad useful pharmacological properties of THCs have rendered them so unique that  Sabinsa markets them as Curcumin C3 Reduct, a self-affirmed GRAS ingredient entirely composed of these reductive metabolites.  ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters